Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 132.37M
March 31, 2026 132.37M
December 31, 2025 128.37M
September 30, 2025 121.27M
June 30, 2025 121.27M
March 31, 2025 121.27M
December 31, 2024 121.27M
September 30, 2024 121.27M
June 30, 2024 121.27M
March 31, 2024 121.27M
December 31, 2023 121.27M
September 30, 2023 121.27M
June 30, 2023 121.27M
March 31, 2023 121.27M
December 31, 2022 121.27M
September 30, 2022 121.27M
June 30, 2022 121.27M
Date Value
March 31, 2022 71.27M
December 31, 2021 71.27M
September 30, 2021 62.83M
June 30, 2021 62.83M
March 31, 2021 62.78M
December 31, 2020 62.58M
September 30, 2020 61.77M
June 30, 2020 61.60M
March 31, 2020 46.40M
December 31, 2019 33.59M
September 30, 2019 33.59M
June 30, 2019 33.59M
March 31, 2019 30.28M
December 31, 2018 30.28M
March 31, 2018 30.28M
December 31, 2017 30.28M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
InMed Pharmaceuticals, Inc. 5.339M
NervGen Pharma Corp. 106.41M
Milestone Pharmaceuticals, Inc. 124.50M
Clearmind Medicine, Inc. 0.2682M
Lexaria Bioscience Corp. 1.652M